Southern African journal of HIV medicine最新文献

{"title":"Dolutegravir resistance in three pregnant and breastfeeding women in South Africa.","authors":"Ninke Fourie, Kate Rees, Denis Mali, Bridget Mugisa, Cara O'Connor, Natasha Davies","doi":"10.4102/sajhivmed.v24i1.1531","DOIUrl":"10.4102/sajhivmed.v24i1.1531","url":null,"abstract":"","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138500623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Confronting the human papillomavirus-HIV intersection: Cervical cytology implications for Kenyan women living with HIV.","authors":"James M Kangethe, Stephen Gichuhi, Eddy Odari, Jillian Pintye, Kenneth Mutai, Leila Abdullahi, Alex Maiyo, Marianne W Mureithi","doi":"10.4102/sajhivmed.v24i1.1508","DOIUrl":"10.4102/sajhivmed.v24i1.1508","url":null,"abstract":"<p><strong>Background: </strong>High-risk human papillomavirus (HR-HPV) is the primary cause of cervical cancer, leading to over 311 000 global deaths, mainly in low- and middle-income countries. Kenyan women living with HIV (WLHIV) face a disproportionate burden of HR-HPV.</p><p><strong>Objectives: </strong>We determined the prevalence of HR-HPV infections and their association with cervical cytology findings among Kenyan WLHIV.</p><p><strong>Method: </strong>We conducted a cross-sectional study among WLHIV attending the HIV care and treatment clinic at the Kenyatta National Hospital (KNH), Kenya's national referral hospital. Study nurses collected a cervical sample with a cytobrush for HR-HPV genotyping using Gene Xpert^® assays and HPV Genotypes 14 Real-TM Quant V67-100FRT. Bivariate analysis explored the associations.</p><p><strong>Results: </strong>We enrolled 647 WLHIV (mean age of 42.8 years), with 97.2% on antiretroviral therapy (ART) and 79% with a suppressed viral load (< 50 copies/mL plasma). The prevalence of any and vaccine-preventable HR-HPV was 34.6% and 29.4%, respectively, with HPV 52 being the most common genotype (13.4%). Among WLHIV with HR-HPV infections, 21.4% had abnormal cervical cytology. Women with multiple HR-HPV infections were more likely to have abnormal cytology compared to those with single HR-HPV infections (34.9 vs 9.3%, adjusted odds ratio [aOR] = 6.2, 95% confidence interval [CI]: 2.7-14.1, <i>P</i> = 0.001). Women with HR-HPV infection (single or multiple) were more likely to be on the second-line ART regimen compared to those without HR-HPV infections (53.1% vs 46.7%, aOR = 2.3, 95% CI: 1.3-4.1, <i>P</i> = 0.005).</p><p><strong>Conclusion: </strong>Among WLHIV at KNH, abnormal cytology was common and more frequent among women with multiple HR-HPV infections.</p>","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71490681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thrombotic thrombocytopaenic purpura in the era of HIV: A single-centre experience.","authors":"Yusuf Moola,&nbsp;Zaheera Cassimjee,&nbsp;Chandni Dayal,&nbsp;Sheetal Chiba,&nbsp;Adekunle Ajayi,&nbsp;Malcolm Davies","doi":"10.4102/sajhivmed.v24i1.1504","DOIUrl":"https://doi.org/10.4102/sajhivmed.v24i1.1504","url":null,"abstract":"<p><strong>Background: </strong>Thrombotic thrombocytopaenia purpura (TTP) is a rare disorder which carries a high mortality. HIV is an important cause of TTP.</p><p><strong>Objectives: </strong>We assessed the presentation and response to plasma exchange (PEX) by HIV status.</p><p><strong>Method: </strong>A single-centre retrospective review of all patients receiving PEX for TTP between 01 January 2010 and 31 December 2019 was undertaken. Demographics and presenting parameters were compared between HIV-associated TTP and other aetiologies using Mann-Whitney <i>U</i> and Kruskal Wallis analysis of variance testing, as appropriate. The effect of aetiology and presenting parameters on PEX duration was modelled using Cox proportional hazards; effect of these variables on mortality and residual renal dysfunction in survivors was analysed using stepwise multivariate regression.</p><p><strong>Results: </strong>Uncontrolled HIV infection was the commonest cause (81.9%) of TTP in the 83 patients identified. Thrombocytopaenia was more severe and neurological deficit more frequent in HIV-associated TTP; but renal dysfunction was milder in this group. Aetiology did not influence mortality risk. Aetiological category and presenting parameters did not predict PEX duration. Residual renal dysfunction was less frequent in survivors of HIV-associated TTP.</p><p><strong>Conclusion: </strong>HIV is an important cause of TTP in the local context. Haematological and neurological involvement are more severe in HIV-associated TTP. Acceptable survival rates are achievable with PEX even in advanced HIV infection; renal sequalae are less common in this group.</p>","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71490683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants.","authors":"Gbolahan Ajibola, Charlotte Mdluli, Kara Bennett, Maureen Sakoi, Oganne Batlang, Joseph Makhema, Shahin Lockman, Roger Shapiro, Landon Myer, Kathleen Powis","doi":"10.4102/sajhivmed.v24i1.1509","DOIUrl":"10.4102/sajhivmed.v24i1.1509","url":null,"abstract":"<p><strong>Background: </strong>Limited data exist on the differential risk of HIV acquisition between infants born preterm versus those born at term to women living with HIV (WLHIV). With a reported increase in preterm delivery among pregnant WLHIV, understanding the risk of vertical transmission of HIV in preterm infants can inform strategies to optimise the timing of diagnostic testing, antiretroviral prophylaxis, and infant feeding.</p><p><strong>Objectives: </strong>To describe the prevalence and timing of HIV acquisition, in utero versus perinatal, among infants with perinatal HIV exposure born prior to 37 weeks completed gestation age compared to those born at term in the Botswana-based Mpepu study and explore predictors of infant HIV acquisition.</p><p><strong>Method: </strong>Using data extracted from the Mpepu study, we describe the prevalence, timing and risk factors for HIV acquisition in infants born preterm versus those born at term. Fisher exact testing was used to test for differences in prevalence and timing of HIV and a multivariable logistic regression model was used to assess risk factors for infant HIV acquisition.</p><p><strong>Results: </strong>2866 infants born to WLHIV were included in this secondary analysis. 532 (19%) were born preterm. There was no observed difference in the prevalence of HIV acquisition among infants born preterm versus at term overall (0.8% vs 0.6%, <i>P</i> = 0.54), at birth (0.2% vs 0.3%, <i>P</i> = 1.00) or between 14 and 34 days post-delivery (0.6% vs 0.3%, <i>P</i> = 0.41). The absence of maternal antiretroviral use during pregnancy significantly predicted infant HIV acquisition, with the risk of HIV acquisition reduced by 96% among infants whose mothers were taking antiretroviral treatment (ART) during pregnancy (adjusted odds ratio: 0.003, confidence interval: 0.01-0.02, <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>There was no observed increase of in utero and peripartum HIV acquisition among infants born preterm following foetal exposure to HIV compared to those born at term.</p>","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623649/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71490682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2023 Southern African HIV Clinicians Society Adult Antiretroviral Therapy Guidelines: What's new?","authors":"Jeremy Nel, Camilla Wattrus, Regina Osih, Graeme Meintjes","doi":"10.4102/sajhivmed.v24i1.1528","DOIUrl":"10.4102/sajhivmed.v24i1.1528","url":null,"abstract":"","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41151672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa.","authors":"Remco P H Peters,&nbsp;James A McIntyre,&nbsp;Nigel Garrett,&nbsp;Adrian J Brink,&nbsp;Connie L Celum,&nbsp;Linda-Gail Bekker","doi":"10.4102/sajhivmed.v24i1.1510","DOIUrl":"10.4102/sajhivmed.v24i1.1510","url":null,"abstract":"<p><p>South Africa has a large burden of bacterial sexually transmitted infections (STIs) with high rates among men who have sex with men (MSM). Randomised controlled trials have recently demonstrated high effectiveness of doxycycline post-exposure prophylaxis (PEP) for prevention of bacterial STIs in MSM, with 70% - 85% reductions in <i>Chlamydia trachomatis</i> infection and syphilis, and approximately 50% reduction in <i>Neisseria gonorrhoeae</i> infection. Doxycycline PEP was not demonstrated to be effective in reducing <i>C. trachomatis</i> and <i>N. gonorrhoeae</i> infection among Kenyan cisgender women. Although no worrisome trends in antimicrobial resistance (AMR) were observed in the trials, important concerns remain about doxycycline PEP and AMR development in STIs, other pathogens, commensals, and the microbiome. Tetracycline resistance in <i>N. gonorrhoeae</i> is already widespread in South Africa, but emergence of AMR in other STIs would be concerning. Larger sample sizes of doxycycline PEP users with longer follow-up time are needed to understand the impact that doxycycline PEP may have on AMR at individual and population level. In this opinion article, we weigh the benefits of doxycycline PEP for prevention of bacterial STIs against the existing AMR concerns and data gaps in the South African context. Based on the current evidence, we conclude that it would be reasonable to offer doxycycline PEP to high-risk MSM on a case-by-case basis, provided that it is offered by experienced sexual health clinicians in settings that have access to diagnostic STI testing and ongoing AMR surveillance.</p>","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41168363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations.","authors":"Jaco Horak, Willem D F Venter, Camilla Wattrus, Nectarios Papavarnavas, Pauline Howell, Gillian Sorour, Carole Wallis, Katherine Gill, Francesca Conradie, Linda-Gail Bekker","doi":"10.4102/sajhivmed.v24i1.1522","DOIUrl":"10.4102/sajhivmed.v24i1.1522","url":null,"abstract":"","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41173681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diminished health and social outcomes among men who have sex with men who use drugs in Zimbabwe.","authors":"Munyaradzi Mapingure,&nbsp;Innocent Chingombe,&nbsp;Tafadzwa Dzinamarira,&nbsp;Chesterfield Samba,&nbsp;Brian Moyo,&nbsp;Owen Mugurungi,&nbsp;Godfrey Musuka","doi":"10.4102/sajhivmed.v24i1.1513","DOIUrl":"10.4102/sajhivmed.v24i1.1513","url":null,"abstract":"of","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41180816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo.","authors":"Limakatso Lebina,&nbsp;Tumiso Malatji,&nbsp;Firdaus Nabeemeeah,&nbsp;Kegaugetswe Motsomi,&nbsp;Tsundzukani Siwelana,&nbsp;Khuthadzo Hlongwane,&nbsp;Neil Martinson","doi":"10.4102/sajhivmed.v24i1.1495","DOIUrl":"10.4102/sajhivmed.v24i1.1495","url":null,"abstract":"<p><strong>Background: </strong>Non-communicable diseases (NCDs) are an emerging global public health problem.</p><p><strong>Objectives: </strong>To assess the prevalence of NCDs and their risk factors among adults on antiretroviral therapy (ART).</p><p><strong>Method: </strong>This was a cross-sectional study (July 2019 - January 2020) in Limpopo, South Africa. Patients were enrolled if they were ≥ 40 years, HIV-positive, and virologically suppressed on ART. Data were analysed descriptively, and a binomial regression model was used to identify risk factors for NCDs.</p><p><strong>Results: </strong>The majority of participants (65%; 319/488) were women. Most (83%; 405/488) were aged 40-59 years; 60% (285/472) were overweight or obese. Based on self-report, 22% (107/488) were currently smokers. Almost half (44%) 213/488) reported daily consumption of vegetables and 65% (319/488) exercised regularly and 39% (190/488) reported treatment for another chronic disease. The leading comorbid conditions were hypertension (32%; 158/488) and diabetes mellitus (5%; 24/488). Risk factors for hypertension included age 60 years and older (relative risk [RR]: 1.72; 95% confidence interval [CI]: 1.29-2.30) diabetes (RR: 1.42; 95% CI: 1.08-1.87), overweight (RR: 1.32; 95% CI: 1.03-1.69) and obesity (RR: 1.69; 95% CI: 1.32-2.17).</p><p><strong>Conclusion: </strong>There is a high prevalence, both of risk factors for NCDs and multimorbidity (> 1 chronic disease) in patients who are ≥ 40 years and virologically suppressed on ART.</p>","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41176107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing very advanced HIV disease in adolescent girls and young women.","authors":"Naseem Cassim, Lindi-Marie Coetzee, Manuel P da Silva, Deborah K Glencross, Wendy S Stevens","doi":"10.4102/sajhivmed.v24i1.1501","DOIUrl":"https://doi.org/10.4102/sajhivmed.v24i1.1501","url":null,"abstract":"<p><strong>Background: </strong>South Africa has the largest HIV epidemic globally, with ~7.5 million people living with HIV in 2021. Adolescent girls (AG) and young women (YW), aged 15-19 years and 20-24 years, are twice as likely to be living with HIV as their male counterparts. The national HIV prevalence for young women was 9.1% (2021), with limited data on disease severity.</p><p><strong>Objectives: </strong>This study assessed very advanced HIV disease (CD4 < 100 cells/μL) in adolescent girls and young women (AGYW) in South Africa.</p><p><strong>Method: </strong>A retrospective descriptive study analysed data collated from the National Health Laboratory Service database for 2017 to 2021 calendar years for AGYW. National and provincial specimen volumes, the percentage of tests with a CD4 < 100 cells/μL and ≥ 100 cells/μL, and the median and interquartile ranges, were calculated. Logistic regression determined the odds ratio for a CD4 < 100 cells/μL, controlling for age category.</p><p><strong>Results: </strong>Data for 1 199 010 CD4 specimens indicated a significant decrease in volumes of 34% from 287 410 (2017) to 189 533 (2021). The percentage of samples with a count < 100 cells/μL ranged from 4.9% to 5.2% for YW versus 5.6% to 6.1% for AG. Provincial data for a CD4 count < 100 cells/μL ranged between 4.5% and 8.3% in AG and 3.6% to 6.3% for YW. Logistic regression indicated a 24% higher likelihood for AG having a CD4 count < 100 cells/μL.</p><p><strong>Conclusion: </strong>The study reported a higher proportion of very advanced HIV disease for AG versus YW nationally, with provincial disparity needing further analysis.</p>","PeriodicalId":94212,"journal":{"name":"Southern African journal of HIV medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138811884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}